FIELD: medicine, sexology. SUBSTANCE: invention relates to treatment of patients with erectile dysfunction caused by an arterial insufficiency of penis cavernosum. Method involves administration of 0.1 mg of medicine / 10 kg body mass as the daily dose. Method provides the stable correction effect of erectile function for 6-18 months. EFFECT: high effectiveness of the method. 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PHARMACOLOGICALLY TREATING PSYCHOGENOUS ERECTILE DYSFUNCTION | 1999 |
|
RU2162324C1 |
METHOD OF TREATMENT OF VENOUS INSUFFICIENCY OF PENIS CAVERNOUS BODIES BY NOVEL SURGICAL INTERVENTION | 1997 |
|
RU2126655C1 |
METHOD TO PREDICT VASCULOGENIC ERECTILE DYSFUNCTION | 2001 |
|
RU2183942C1 |
METHOD OF TREATING ERECTILE DYSFUNCTION IN PATIENTS SUFFERING RADICAL PROSTATECTOMY OR BRACHYTHERAPY | 2020 |
|
RU2741204C2 |
METHOD OF TREATING ERECTILE DYSFUNCTION | 2023 |
|
RU2823748C1 |
METHOD FOR TREATING ERECTILE DYSFUNCTION | 2003 |
|
RU2270000C2 |
METHOD FOR ERECTILE DYSFUNCTION TREATMENT | 2016 |
|
RU2622757C1 |
METHOD FOR TREATING ERECTILE DYSFUNCTION | 2002 |
|
RU2233183C1 |
METHOD OF SURGICAL TREATMENT OF VASCULAR ERECTILE MALFUNCTION | 1999 |
|
RU2136225C1 |
METHOD FOR DIAGNOSTICS OF VASCULAR AND GENETIC ERECTILE DYSFUNCTION | 2006 |
|
RU2336820C2 |
Authors
Dates
1999-09-10—Published
1998-01-12—Filed